When it comes to the complexities of cell therapy drug development and manufacturing, you need a CMO partner that offers manufacturing expertise, instills investor confidence, and ensures a reliable supply chain.
A pioneer in the development and delivery of complex cellular therapies, Dendreon combines technological innovation, world-class manufacturing, and process excellence to deliver a reliable path to commercialization for the biopharmaceutical industry.
As 1 of only 4 companies manufacturing cell therapies for commercial use in the United States, Dendreon understands the complexities of cell therapy manufacturing, and has been delivering on this promise since 2010.
Whether it’s navigating the highly regulated drug-development framework required by the Food and Drug Administration (FDA) or scaling production to meet deadlines and demand, our expert staff can help you navigate the most challenging phase of commercialization for CAR-Ts, autologous, or allogeneic cell therapies.
PROVENGE® (sipuleucel-T) is a prescription medicine that is used to treat certain patients with advanced prostate cancer. PROVENGE is made from your own immune cells.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information.